Status:
COMPLETED
Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Fatigue
Leukemia
Eligibility:
All Genders
1-20 years
Brief Summary
RATIONALE: Gathering information about metabolic syndrome from young patients with acute lymphoblastic leukemia may help doctors learn more about the disease. PURPOSE: This phase I trial is studying ...
Detailed Description
OBJECTIVES: Primary * To determine the incidence and prevalence of the components of metabolic syndrome (e.g., obesity, hypertension, dyslipidemia, and insulin resistance) in pediatric patients with...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Part 1
- Diagnosis of precursor B-cell acute lymphoblastic leukemia (ALL)
- In first remission
- In first 3 months of maintenance therapy
- No T-cell ALL, very high-risk ALL, or infant ALL (\< 1 year old at diagnosis)
- Part 2
- Diagnosis of precursor B-cell or T-cell ALL
- In first remission
- Must have been diagnosed and treated (at least to the maintenance phase) at the Division of Pediatric Oncology at the Vanderbilt-Ingram Cancer Center within the past 7 years
- No very high-risk ALL or infant ALL (\< 1 year old at diagnosis)
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior or concurrent cranial radiotherapy (Part 1)
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT00801346
Start Date
November 1 2008
End Date
April 1 2016
Last Update
April 21 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
2
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
3
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838